These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1727907)
1. Production of anti-P1A monoclonal antibodies. Ryckewaert JJ; Schweizer B; Chapel A; Marguerie G J Lab Clin Med; 1992 Jan; 119(1):52-6. PubMed ID: 1727907 [TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2. Weiss EJ; Goldschmidt-Clermont PJ; Grigoryev D; Jin Y; Kickler TS; Bray PF Tissue Antigens; 1995 Nov; 46(5):374-81. PubMed ID: 8838346 [TBL] [Abstract][Full Text] [Related]
3. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. Wang R; Furihata K; McFarland JG; Friedman K; Aster RH; Newman PJ J Clin Invest; 1992 Nov; 90(5):2038-43. PubMed ID: 1430225 [TBL] [Abstract][Full Text] [Related]
4. [Platelet antigens, antibodies and related clinical conditions]. Muñiz Díaz E Sangre (Barc); 1991 Oct; 36(5):395-415. PubMed ID: 1840085 [No Abstract] [Full Text] [Related]
5. Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes. Goldberger A; Kolodziej M; Poncz M; Bennett JS; Newman PJ Blood; 1991 Aug; 78(3):681-7. PubMed ID: 1713513 [TBL] [Abstract][Full Text] [Related]
6. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders. Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388 [TBL] [Abstract][Full Text] [Related]
7. The P1A alloantigen system is a sensitive indicator of the structural integrity of the amino-terminal domain of the human integrin beta 3 subunit. Kunicki TJ; Honda S; Dawson B; Honda Y; Ruan C; Aster RH Blood Cells Mol Dis; 1995; 21(2):131-41. PubMed ID: 8846042 [TBL] [Abstract][Full Text] [Related]
8. Suppression of the antibody response to a polymorphic peptide from the platelet alloantigen integrin beta3 with low molecular weight antigen arrays. Watson DC; Reim J; Dintzis HM J Immunol; 1996 Apr; 156(7):2443-50. PubMed ID: 8786303 [TBL] [Abstract][Full Text] [Related]
9. Human platelet alloantigens: recent findings, new perspectives. Newman PJ; Valentin N Thromb Haemost; 1995 Jul; 74(1):234-9. PubMed ID: 8578464 [No Abstract] [Full Text] [Related]
10. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295 [TBL] [Abstract][Full Text] [Related]
11. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
12. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844 [TBL] [Abstract][Full Text] [Related]
13. [A single base substitution is responsible for the origin of "private" platelet Sra antigens affects molecular weight polymorphism of glycoproteins IIIa]. Kroll H; Santoso S; Kalb R; Böhringer M; Walka M; Kiefel V; Mueller-Eckhardt C Beitr Infusionsther Transfusionsmed; 1994; 32():225-8. PubMed ID: 9480094 [TBL] [Abstract][Full Text] [Related]
14. Human platelet antigen 3 (HPA-3): localization of the determinant of the alloantibody Lek(a) (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates. Djaffar I; Vilette D; Pidard D; Wautier JL; Rosa JP Thromb Haemost; 1993 May; 69(5):485-9. PubMed ID: 7686694 [TBL] [Abstract][Full Text] [Related]
15. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization. Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959 [TBL] [Abstract][Full Text] [Related]
16. Endocytosis of monoclonal anti-glycoprotein IIb/IIIa antibody in unstimulated platelets. Kokawa T; Nomura S; Yasunaga K Thromb Haemost; 1993 Jan; 69(1):90. PubMed ID: 8446946 [No Abstract] [Full Text] [Related]
17. Monoclonal antibodies reactive to human platelets: analysis of their specificities, detected antigen molecules, and their effects on platelet function. Furukawa K; Hayashi K; Naoe T; Takamoto S; Shiku H; Yamada K Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):914-25. PubMed ID: 3687336 [No Abstract] [Full Text] [Related]
18. Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods. Morel-Kopp MC; Clemenceau S; Aurousseau MH; Schlegel N; Kaplan C Transfus Med; 1994 Mar; 4(1):9-14. PubMed ID: 7912136 [TBL] [Abstract][Full Text] [Related]
19. [Study on polymorphism of membrane glycoprotein genes related to human platelet alloantigens]. Lan XF; Ying YL; Liu Y; Xu XG; Zhu FM; Lv HJ; Yan LX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):37-41. PubMed ID: 21287507 [TBL] [Abstract][Full Text] [Related]
20. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes. Liu LX; Nardi M; Flug F; Karpatkin S Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]